Deaths in Immune-Therapy Trials Haunt the Experimental Cancer Treatment
by from MIT Technology Review on (#23JZH)
Companies are racing to develop a new type of cancer therapy, but scientists are still assessing their safety.Companies are racing to develop a new type of cancer therapy, but scientists are still assessing their safety.